Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-carboxylate CAS 161797-99-5 Febuxostat Entèmedyè Pite> 99.0% Faktori

Deskripsyon kout:

Non chimik: Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-carboxylate

CAS: 161797-99-5

Pite:> 99.0% (HPLC)

Aparans: Limyè jòn poud blan poud

Entèmedyè Febuxostat (CAS: 144060-53-7)

Segondè Kalite, Pwodiksyon Komèsyal

E-Mail: alvin@ruifuchem.com

Voye imèl ba nou

Pwodwi detay

Pwodwi ki gen rapò

Tags pwodwi

Deskripsyon:

Ruifu Chemical Supply Febuxostat Entèmedyè ki gen rapò:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS 25984-63-8
Etil 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2-(3-Cyano-4-Isobutoxyphenyl) -4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2-(3-Formil-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161798-01-2
Ethyl 2-(3-Formil-4-Isobutoxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161798-03-4
Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-carboxylate CAS 161797-99-5

Pwopriyete chimik:

Non Chimik	Etil 2-(4-Idroksifenil)-4-Methylthiazole-5-Carboxylate
Sinonim	Febuxostat Entèmedyè
Nimewo CAS	161797-99-5
Nimewo CAT	RF-PI1122
Estati Stock	Nan Stock, Kapasite Pwodiksyon 100 Tòn / Ane
Fòmil molekilè	C13H13NO3S
Pwa molekilè	263.31
Pwen k ap fonn	180℃
Mak	Ruifu Chimik

Espesifikasyon:

Atik	Espesifikasyon
Aparans	Limyè jòn poud blan poud
Idantifikasyon	Pa HPLC;Pa HNMR
Pèt sou siye	<0.50%
Rezid sou Ighition	<0.30%
Single enpurte	<0.50%
Enpurte total	<1.00%
Pite / Metòd analiz	>99.0% (pa HPLC)
Tès Creole	Enterprise Standard
Itilizasyon	Entèmedyè Febuxostat (CAS: 144060-53-7)

Pake & Depo:

Pake: Boutèy, sak papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an

Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite

Avantaj:

FAQ:

Aplikasyon:

Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate (CAS: 161797-99-5) yo itilize nan sentèz Febuxostat (CAS: 144060-53-7), yon inibitè xanthine oksidaz / xanthine dehydrogenase.Yo itilize pou tretman ipèrisemi ak gout kwonik.40-120 mg / jou febuxostat te pwouve efikas nan bese nivo serik urat lè yo te administre pou jere ipèurisemi nan pasyan ki gen gout.Fabuxostat te dekouvri pa Teijin Pharmaceuticals ak lisansye nan TAP Pharmaceuticals (ki se kounye a yon pati nan Takeda Pharmaceuticals) e li te apwouve Ozetazini pou tretman ipèrisemi nan pasyan ki gen gout.